Baker Bros. Advisors’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-20,892
Closed -$370K 134
2016
Q4
$370K Hold
20,892
﹤0.01% 124
2016
Q3
$488K Hold
20,892
﹤0.01% 127
2016
Q2
$390K Hold
20,892
﹤0.01% 130
2016
Q1
$380K Hold
20,892
﹤0.01% 128
2015
Q4
$440K Hold
20,892
﹤0.01% 128
2015
Q3
$385K Hold
20,892
﹤0.01% 127
2015
Q2
$707K Sell
20,892
-103,363
-83% -$4.16M 0.01% 120
2015
Q1
$5.98M Sell
124,255
-1,892
-1% -$85.8K 0.05% 71
2014
Q4
$2.8M Buy
126,147
+47,985
+61% +$1.11M 0.03% 90
2014
Q3
$1.48M Hold
78,162
0.02% 92
2014
Q2
$2.11M Buy
+78,162
New +$1.98M 0.03% 87
2014
Q1
Sell
-20,000
Closed -$476K 112
2013
Q4
$476K Buy
+20,000
New +$559K 0.01% 91

Other funds holding FMI

Baker Bros. Advisors's FMI Position: Q1 2017 in Review

Baker Bros. Advisors sold out of Foundation Medicine, Inc. (FMI) in Q1 2017, closing a stake of 20,892 shares — an estimated $370K sold.

Baker Bros. Advisors first reported a position in FMI in Q4 2013 and held it in 12 quarters. The position peaked at $5.98M in Q1 2015. 93 funds tracked by Wall St. Rank hold FMI as of Q1 2017.

  • Baker Bros. Advisors reported no remaining Foundation Medicine, Inc. position as of Q1 2017 after selling out during the quarter.
  • Baker Bros. Advisors sold 20,892 Foundation Medicine, Inc. shares in Q1 2017, an estimated $370K.
  • Baker Bros. Advisors first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 12 quarters.
  • Baker Bros. Advisors's Foundation Medicine, Inc. position peaked at $5.98M in Q1 2015.
  • 93 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2017.

Based on Baker Bros. Advisors's 13F filing for Q1 2017, filed 15 May 2017.